The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Rajiv Agarwal

Correspondence and offprint requests to: Rajiv Agarwal; E-mail:

[email]@iupui.edu

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Correspondence and offprint requests to: Rajiv Agarwal; E-mail:. 2012
  • Indiana University School of Medicine and Richard L. Roudebush Veterans Administration Medical Center, Indianapolis, IN. Electronic address:. 1999 - 2012
  • Indiana University and VAMC, 1481 West 10th Street, Indianapolis, IN 46202. 2011
  • Division of Nephrology, Indianapolis, USA. 2009

References

  1. Prevalence, determinants and prognosis of pulmonary hypertension among hemodialysis patients. Agarwal, R. Nephrol. Dial. Transplant. (2012) [Pubmed]
  2. Thiazide diuretics in advanced chronic kidney disease. Agarwal, R., Sinha, A.D. J. Am. Soc. Hypertens (2012) [Pubmed]
  3. Debate from the 2012 ASH Annual Scientific Sessions: should blood pressure be reduced in hemodialysis patients? pro position. Agarwal, R.L. J. Am. Soc. Hypertens (2012) [Pubmed]
  4. Resistant hypertension and the neglected antihypertensive: sodium restriction. Agarwal, R. Nephrol. Dial. Transplant. (2012) [Pubmed]
  5. Long-term retinal, renal and cardiovascular outcomes in diabetic chronic kidney disease without proteinuria. Agarwal, R., Debella, Y.T., Giduma, H.D., Light, R.P. Nephrol. Dial. Transplant. (2012) [Pubmed]
  6. Body mass index-mortality paradox in hemodialysis: can it be explained by blood pressure? Agarwal, R. Hypertension (2011) [Pubmed]
  7. Chronic Kidney Disease as a Coronary Disease Equivalent--A Comparison with Diabetes over a Decade. Debella, Y.T., Giduma, H.D., Light, R.P., Agarwal, R. Clin. J. Am. Soc. Nephrol (2011) [Pubmed]
  8. Patterns and prognostic value of total and differential leukocyte count in chronic kidney disease. Agarwal, R., Light, R.P. Clin. J. Am. Soc. Nephrol (2011) [Pubmed]
  9. Toward a Definition of Masked Hypertension and White-Coat Hypertension among Hemodialysis Patients. Agarwal, R., Sinha, A.D., Light, R.P. Clin. J. Am. Soc. Nephrol (2011) [Pubmed]
  10. Inferior vena cava diameter and left atrial diameter measure volume but not dry weight. Agarwal, R., Bouldin, J.M., Light, R.P., Garg, A. Clin. J. Am. Soc. Nephrol (2011) [Pubmed]
  11. Interdialytic hypertension-an update. Agarwal, R. Adv. Chronic. Kidney. Dis (2011) [Pubmed]
  12. Role of home blood pressure monitoring in overcoming therapeutic inertia and improving hypertension control: a systematic review and meta-analysis. Agarwal, R., Bills, J.E., Hecht, T.J., Light, R.P. Hypertension (2011) [Pubmed]
  13. Proteinuria induced by parenteral iron in chronic kidney disease--a comparative randomized controlled trial. Agarwal, R., Leehey, D.J., Olsen, S.M., Dahl, N.V. Clin. J. Am. Soc. Nephrol (2011) [Pubmed]
  14. Blood pressure and mortality among hemodialysis patients. Agarwal, R. Hypertension (2010) [Pubmed]
  15. Are vitamin D receptor agonists like angiotensin-converting enzyme inhibitors without side effects? Agarwal, R. Kidney Int. (2010) [Pubmed]
  16. Median intradialytic blood pressure can track changes evoked by probing dry-weight. Agarwal, R., Light, R.P. Clin. J. Am. Soc. Nephrol (2010) [Pubmed]
  17. The effect of measuring ambulatory blood pressure on nighttime sleep and daytime activity--implications for dipping. Agarwal, R., Light, R.P. Clin. J. Am. Soc. Nephrol (2010) [Pubmed]
  18. Intradialytic hypertension is a marker of volume excess. Agarwal, R., Light, R.P. Nephrol. Dial. Transplant. (2010) [Pubmed]
  19. Debate: CON Position. People with chronic kidney disease should have a blood pressure lower than 130/80 mm Hg. Agarwal, R. Am. J. Nephrol. (2010) [Pubmed]
  20. Individualizing decision-making--resurrecting the doctor-patient relationship in the anemia debate. Agarwal, R. Clin. J. Am. Soc. Nephrol (2010) [Pubmed]
  21. Developing a self-administered CKD symptom assessment instrument. Agarwal, R. Nephrol. Dial. Transplant. (2010) [Pubmed]
  22. Physical activity is a determinant of circadian blood pressure variation in chronic kidney disease. Agarwal, R., Light, R.P. Am. J. Nephrol. (2010) [Pubmed]
  23. Regulation of circadian blood pressure: from mice to astronauts. Agarwal, R. Curr. Opin. Nephrol. Hypertens. (2010) [Pubmed]
  24. Assessment of iothalamate plasma clearance: duration of study affects quality of GFR. Agarwal, R., Bills, J.E., Yigazu, P.M., Abraham, T., Gizaw, A.B., Light, R.P., Bekele, D.M., Tegegne, G.G. Clin. J. Am. Soc. Nephrol (2009) [Pubmed]
  25. Nocturia, nocturnal activity, and nondipping. Agarwal, R., Light, R.P., Bills, J.E., Hummel, L.A. Hypertension (2009) [Pubmed]
  26. Dry-weight reduction in hypertensive hemodialysis patients (DRIP): a randomized, controlled trial. Agarwal, R., Alborzi, P., Satyan, S., Light, R.P. Hypertension (2009) [Pubmed]
  27. Chronobiology of arterial hypertension in hemodialysis patients: implications for home blood pressure monitoring. Agarwal, R., Light, R.P. Am. J. Kidney Dis. (2009) [Pubmed]
  28. Blood pressure components and the risk for end-stage renal disease and death in chronic kidney disease. Agarwal, R. Clin. J. Am. Soc. Nephrol (2009) [Pubmed]
  29. Circadian blood pressure classification scheme and the health of patients with chronic kidney disease. Agarwal, R., Kariyanna, S.S., Light, R.P. Am. J. Nephrol. (2009) [Pubmed]
  30. GFR, proteinuria and circadian blood pressure. Agarwal, R., Light, R.P. Nephrol. Dial. Transplant. (2009) [Pubmed]
  31. Vitamin D, proteinuria, diabetic nephropathy, and progression of CKD. Agarwal, R. Clin. J. Am. Soc. Nephrol (2009) [Pubmed]
  32. Out-of-office blood pressure monitoring in chronic kidney disease. Agarwal, R., Peixoto, A.J., Santos, S.F., Zoccali, C. Blood. Press. Monit (2009) [Pubmed]
  33. Home blood pressure measurements for managing hypertension in hemodialysis patients. Agarwal, R., Satyan, S., Alborzi, P., Light, R.P., Tegegne, G.G., Mazengia, H.S., Yigazu, P.M. Am. J. Nephrol. (2009) [Pubmed]
  34. Cardiovascular protection with antihypertensive drugs in dialysis patients: systematic review and meta-analysis. Agarwal, R., Sinha, A.D. Hypertension (2009) [Pubmed]
  35. Volume-associated ambulatory blood pressure patterns in hemodialysis patients. Agarwal, R. Hypertension (2009) [Pubmed]
  36. Home and ambulatory blood pressure monitoring in chronic kidney disease. Agarwal, R. Curr. Opin. Nephrol. Hypertens. (2009) [Pubmed]
  37. Prognostic value of circadian blood pressure variation in chronic kidney disease. Agarwal, R., Kariyanna, S.S., Light, R.P. Am. J. Nephrol. (2009) [Pubmed]
  38. Competing risk factor analysis of end-stage renal disease and mortality in chronic kidney disease. Agarwal, R., Bunaye, Z., Bekele, D.M., Light, R.P. Am. J. Nephrol. (2008) [Pubmed]
  39. Location not quantity of blood pressure measurements predicts mortality in hemodialysis patients. Agarwal, R., Andersen, M.J., Light, R.P. Am. J. Nephrol. (2008) [Pubmed]
  40. Paricalcitol reduces albuminuria and inflammation in chronic kidney disease: a randomized double-blind pilot trial. Alborzi, P., Patel, N.A., Peterson, C., Bills, J.E., Bekele, D.M., Bunaye, Z., Light, R.P., Agarwal, R. Hypertension (2008) [Pubmed]
  41. On the importance of pedal edema in hemodialysis patients. Agarwal, R., Andersen, M.J., Pratt, J.H. Clin. J. Am. Soc. Nephrol (2008) [Pubmed]
  42. Temperature sensitivity and fluorescence detection. Agarwal, R. J. Sep. Sci (2008) [Pubmed]
  43. Serum albumin is strongly associated with erythropoietin sensitivity in hemodialysis patients. Agarwal, R., Davis, J.L., Smith, L. Clin. J. Am. Soc. Nephrol (2008) [Pubmed]
  44. Prognostic significance of between-arm blood pressure differences. Agarwal, R., Bunaye, Z., Bekele, D.M. Hypertension (2008) [Pubmed]
  45. Diagnostic utility of blood volume monitoring in hemodialysis patients. Agarwal, R., Kelley, K., Light, R.P. Am. J. Kidney Dis. (2008) [Pubmed]
  46. Does ferric gluconate lower epoetin requirements in hemodialysis patients with high ferritin levels? Agarwal, R. Nat. Clin. Pract. Nephrol (2008) [Pubmed]
  47. Physical activity and hemodynamic reactivity in chronic kidney disease. Agarwal, R., Light, R.P. Clin. J. Am. Soc. Nephrol (2008) [Pubmed]
  48. Arterial stiffness and interdialytic weight gain influence ambulatory blood pressure patterns in hemodialysis patients. Agarwal, R., Light, R.P. Am. J. Physiol. Renal Physiol. (2008) [Pubmed]
  49. Diagnosing hypertension by intradialytic blood pressure recordings. Agarwal, R., Metiku, T., Tegegne, G.G., Light, R.P., Bunaye, Z., Bekele, D.M., Kelley, K. Clinical J. American Society Nephrology : Cjasn (2008) [Pubmed]
  50. The challenge of discovering patient-level cardiovascular risk factors in chronic kidney disease. Agarwal, R. Kidney Int. (2008) [Pubmed]
  51. Reproducibility of renal function measurements in adult men with diabetic nephropathy: research and clinical implications. Agarwal, R. Am. J. Nephrol. (2007) [Pubmed]
  52. Dialysis dose and the diagnosis of hypertension in hemodialysis patients. Agarwal, R., Saha, C. Blood. Press. Monit (2007) [Pubmed]
  53. Ambulatory blood pressure and cardiovascular events in chronic kidney disease. Agarwal, R. Semin. Nephrol. (2007) [Pubmed]
  54. Iron sucrose causes greater proteinuria than ferric gluconate in non-dialysis chronic kidney disease. Agarwal, R., Rizkala, A.R., Kaskas, M.O., Minasian, R., Trout, J.R. Kidney Int. (2007) [Pubmed]
  55. Relationship between circadian blood pressure variation and circadian protein excretion in CKD. Agarwal, R. Am. J. Physiol. Renal Physiol. (2007) [Pubmed]
  56. Antihypertensive agents and arterial stiffness: relevance to reducing cardiovascular risk in the chronic kidney disease patient. Agarwal, R. Curr. Opin. Nephrol. Hypertens. (2007) [Pubmed]
  57. Nonhematological benefits of iron. Agarwal, R. Am. J. Nephrol. (2007) [Pubmed]
  58. How should hypertension be assessed and managed in hemodialysis patients? Home BP, not dialysis unit BP, should be used for managing hypertension. Agarwal, R. Semin. Dial (2007) [Pubmed]
  59. Prognostic importance of ambulatory blood pressure recordings in patients with chronic kidney disease. Agarwal, R., Andersen, M.J. Kidney Int. (2006) [Pubmed]
  60. Pre- and postdialysis blood pressures are imprecise estimates of interdialytic ambulatory blood pressure. Agarwal, R., Peixoto, A.J., Santos, S.F., Zoccali, C. Clin. J. Am. Soc. Nephrol (2006) [Pubmed]
  61. Out-of-hemodialysis-unit blood pressure is a superior determinant of left ventricular hypertrophy. Agarwal, R., Brim, N.J., Mahenthiran, J., Andersen, M.J., Saha, C. Hypertension (2006) [Pubmed]
  62. Blood pressure recordings within and outside the clinic and cardiovascular events in chronic kidney disease. Agarwal, R., Andersen, M.J. Am. J. Nephrol. (2006) [Pubmed]
  63. Management of hypertension in hemodialysis patients. Agarwal, R. Hemodial. Int (2006) [Pubmed]
  64. Anti-inflammatory effects of short-term pioglitazone therapy in men with advanced diabetic nephropathy. Agarwal, R. Am. J. Physiol. Renal Physiol. (2006) [Pubmed]
  65. Prognostic importance of clinic and home blood pressure recordings in patients with chronic kidney disease. Agarwal, R., Andersen, M.J. Kidney Int. (2006) [Pubmed]
  66. Effects of statins on renal function. Agarwal, R. Am. J. Cardiol. (2006) [Pubmed]
  67. Home blood pressure monitoring improves the diagnosis of hypertension in hemodialysis patients. Agarwal, R., Andersen, M.J., Bishu, K., Saha, C. Kidney Int. (2006) [Pubmed]
  68. Hypertension diagnosis and prognosis in chronic kidney disease with out-of-office blood pressure monitoring. Agarwal, R. Curr. Opin. Nephrol. Hypertens. (2006) [Pubmed]
  69. Proinflammatory effects of iron sucrose in chronic kidney disease. Agarwal, R. Kidney Int. (2006) [Pubmed]
  70. Overcoming barriers that inhibit proper treatment of anemia. Agarwal, R. Kidney Int. Suppl. (2006) [Pubmed]
  71. A randomized controlled trial of oral versus intravenous iron in chronic kidney disease. Agarwal, R., Rizkala, A.R., Bastani, B., Kaskas, M.O., Leehey, D.J., Besarab, A. Am. J. Nephrol. (2006) [Pubmed]
  72. Strategies for successful patient oriented research: why did I (not) get funded?. Agarwal, R., Chertow, G.M., Mehta, R.L. Clinical J. American Society Nephrology : Cjasn (2006) [Pubmed]
  73. On the nature of proteinuria with acute renal injury in patients with chronic kidney disease. Agarwal, R. Am. J. Physiol. Renal Physiol. (2005) [Pubmed]
  74. Hypertension and survival in chronic hemodialysis patients--past lessons and future opportunities. Agarwal, R. Kidney Int. (2005) [Pubmed]
  75. A pilot randomized controlled trial of renal protection with pioglitazone in diabetic nephropathy. Agarwal, R., Saha, C., Battiwala, M., Vasavada, N., Curley, T., Chase, S.D., Sachs, N., Semret, M.H. Kidney Int. (2005) [Pubmed]
  76. Hypertension in chronic kidney disease and dialysis: pathophysiology and management. Agarwal, R. Cardiol. Clin (2005) [Pubmed]
  77. Correlates of systolic hypertension in patients with chronic kidney disease. Agarwal, R., Andersen, M.J. Hypertension (2005) [Pubmed]
  78. The role of statins in chronic kidney disease. Agarwal, R., Curley, T.M. Am. J. Med. Sci. (2005) [Pubmed]
  79. Smoking, oxidative stress and inflammation: impact on resting energy expenditure in diabetic nephropathy. Agarwal, R. BMC. Nephrol (2005) [Pubmed]
  80. Antiproteinuric effect of oral paricalcitol in chronic kidney disease. Agarwal, R., Acharya, M., Tian, J., Hippensteel, R.L., Melnick, J.Z., Qiu, P., Williams, L., Batlle, D. Kidney Int. (2005) [Pubmed]
  81. Evaluation of kidney function in patients with acute renal failure using high-performance liquid chromatography: a case report. Agarwal, R., Vasavada, N., Chase, S.D. Pharmacotherapy (2004) [Pubmed]
  82. Oxidative stress in hypertension and chronic kidney disease: role of angiotensin II. Agarwal, R., Campbell, R.C., Warnock, D.G. Semin. Nephrol. (2004) [Pubmed]
  83. Oxidative stress and renal injury with intravenous iron in patients with chronic kidney disease. Agarwal, R., Vasavada, N., Sachs, N.G., Chase, S. Kidney Int. (2004) [Pubmed]
  84. Chronic kidney disease is associated with oxidative stress independent of hypertension. Agarwal, R. Clin. Nephrol. (2004) [Pubmed]
  85. Transferrin saturation with intravenous irons: an in vitro study. Agarwal, R. Kidney Int. (2004) [Pubmed]
  86. Exploring the paradoxical relationship of hypertension with mortality in chronic hemodialysis. Agarwal, R. Hemodial. Int (2004) [Pubmed]
  87. Proinflammatory effects of oxidative stress in chronic kidney disease: role of additional angiotensin II blockade. Agarwal, R. Am. J. Physiol. Renal Physiol. (2003) [Pubmed]
  88. Liquid chromatography for iothalamate in biological samples. Agarwal, R., Vasavada, N., Chase, S.D. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. (2003) [Pubmed]
  89. Ambulatory GFR measurement with cold iothalamate in adults with chronic kidney disease. Agarwal, R. Am. J. Kidney Dis. (2003) [Pubmed]
  90. Prevalence, treatment, and control of hypertension in chronic hemodialysis patients in the United States. Agarwal, R., Nissenson, A.R., Batlle, D., Coyne, D.W., Trout, J.R., Warnock, D.G. Am. J. Med. (2003) [Pubmed]
  91. Is continuous veno-venous hemofiltration for acetaminophen-induced acute liver and renal failure worthwhile?. Agarwal, R., Farber, M.O. Clin. Nephrol. (2002) [Pubmed]
  92. Add-on angiotensin II receptor blockade lowers urinary transforming growth factor-beta levels. Agarwal, R., Siva, S., Dunn, S.R., Sharma, K. Am. J. Kidney Dis. (2002) [Pubmed]
  93. Dipstick proteinuria: can it guide hypertension management?. Agarwal, R., Panesar, A., Lewis, R.R. Am. J. Kidney Dis. (2002) [Pubmed]
  94. Rapid, fluorimetric-liquid chromatographic determination of malondialdehyde in biological samples. Agarwal, R., Chase, S.D. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. (2002) [Pubmed]
  95. Rapid microplate method for PAH estimation. Agarwal, R. Am. J. Physiol. Renal Physiol. (2002) [Pubmed]
  96. How to diagnose hypertension in hemodialysis patients?. Agarwal, R. Minerva. Urol. Nefrol (2002) [Pubmed]
  97. Issues related to iron replacement in chronic kidney disease. Agarwal, R., Warnock, D. Semin. Nephrol. (2002) [Pubmed]
  98. Add-on angiotensin receptor blockade with maximized ACE inhibition. Agarwal, R. Kidney Int. (2001) [Pubmed]
  99. Treatment of hypertension in patients with diabetes mellitus. Agarwal, R. Indian. Heart. J (2001) [Pubmed]
  100. Buzz in the axilla: a new physical sign in hemodialysis forearm graft evaluation. Agarwal, R., McDougal, G. Am. J. Kidney Dis. (2001) [Pubmed]
  101. Prediction of hypertension in chronic hemodialysis patients. Agarwal, R., Lewis, R.R. Kidney Int. (2001) [Pubmed]
  102. Lisinopril therapy for hemodialysis hypertension: hemodynamic and endocrine responses. Agarwal, R., Lewis, R., Davis, J.L., Becker, B. Am. J. Kidney Dis. (2001) [Pubmed]
  103. Role of home blood pressure monitoring in hemodialysis patients. Agarwal, R. Am. J. Kidney Dis. (1999) [Pubmed]
  104. Supervised atenolol therapy in the management of hemodialysis hypertension. Agarwal, R. Kidney Int. (1999) [Pubmed]
  105. Monitoring interposition graft venous pressures at higher blood-flow rates improves sensitivity in predicting graft failure. Agarwal, R., Davis, J.L. Am. J. Kidney Dis. (1999) [Pubmed]
 
WikiGenes - Universities